Skip to content

Post-exercise Hypotension After a Power Training Session in Older Adults With Hypertension

Effect of a Power Training Session on Ambulatory Blood Pressure in Older Adults With Hypertension: a Randomized Crossover Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03615625
Enrollment
24
Registered
2018-08-06
Start date
2018-06-12
Completion date
2020-01-01
Last updated
2021-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Exercise, Aging, Ambulatory Blood Pressure Monitoring, Power Exercise

Brief summary

The main purpose of the present study was to evaluate the effect of a power training session on office and 24h ambulatory blood pressure in older adults with hypertension. As secondary outcomes, the investigators compared post-exercise hypotension, BP variability, and endothelial function between older men and women with hypertension. The working hypothesis was that a single bout of power exercise would decrease both office and 24 h BP in comparison to a non-exercising control session and men and women would respond differently after a power training session.

Detailed description

Participants randomly performed two experimental sessions: power exercise training (PT) and non-exercising control at seated rest (Con). They maintained their current antihypertensive medications throughout the trial. Each session was composed of 20 min of rest in the supine position, 40 min of PT or Con protocols, and 60 min of rest in supine position after protocols. The PT was composed of 3 sets of 8-10 repetitions of 5 exercises performed in the following order: leg press, bench press, knee extension, upright row, and knee flexion, using an intensity corresponding to 50 % of 1-RM and two-minute intervals between sets and exercises. The concentric phase of exercises during each repetition was performed as fast as possible while the eccentric phase lasted 1-2 seconds. During the Con, the participants remained seated rest on the same exercise machines, but without any exercise. Standardized office BP was performed before and during the first hour (in intervals of 15 min) after exercise and control sessions. Together with the office BP evaluation in the pre and post sessions, the endothelium-dependent brachial vascular function was evaluated using Flow-mediated dilation. Afterwards, participants underwent 24h ambulatory BP monitoring..

Interventions

BEHAVIORALPower Training Session

3 sets of 8-10 repetitions of 5 exercises performed in the following order: leg press, bench press, knee extension, upright row, and knee flexion, using an intensity corresponding to 50 % of 1-RM and two-minute intervals between sets and exercises. The concentric phase of exercises during each repetition was performed as fast as possible while the eccentric phase lasted 1-2 seconds.

Sponsors

Federal University of Rio Grande do Sul
CollaboratorOTHER
Hospital de Clinicas de Porto Alegre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

The randomization list was generated by an epidemiologist using a computer software. This epidemiologist did not participate in the recruitment or assignment to the experimental sessions. Participants and the research team were blinded to the randomization list until the moment of assignment.

Intervention model description

A randomized controlled clinical trial with crossover design was performed in order to evaluate the effect of a power training session on office and 24h ambulatory blood pressure in older adults with hypertension.

Eligibility

Sex/Gender
ALL
Age
60 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Office blood pressure between 130-179 and 80-110 mmHg for systolic and diastolic blood pressure, respectively; * Non-engaged in structured programs of exercise for the last 3 months since the beginning of this study; * Able to perform the proposed exercises.

Exclusion criteria

* Underlying cardiovascular disease previously diagnosticated by a doctor, occurred in the last 24 months, such as: acute myocardial infarction, angina, stroke or heart failure; * Diseases that reduce life expectancy; * Smokers and ex-smokers for less than six months; * BMI \> 39.9 kg/m² * diabetic proliferative retinopathy.

Design outcomes

Primary

MeasureTime frameDescription
Ambulatory Blood Pressure Monitoring24 hours after control and power training exercise sessionMean 24-h, day-time, night-time of blood pressure in mmHg will be assessed after each experimental session (power training session and control session)

Secondary

MeasureTime frameDescription
Office Systolic Blood Pressure60 minutes after control and power training exercise sessionSystolic blood pressure in mmHg will be measured using automatic oscillometric before and after each experimental session throughout one hour
Office Diastolic Blood Pressure60 minutes after control and power training exercise sessionDiastolic blood pressure in mmHg will be measured using automatic oscillometric before and after each experimental session throughout one hour
Endothelial Function60 minutes after control and power training exercise sessionFlow-mediated dilatation (FMD) assessed through high resolution ultrasonography before and after each experimental session throughout one hour
Blood Pressure Variability24 hours after control and power training exercise sessionSystolic and diastolic BP values obtained in the 24-hour ambulatory blood pressure monitoring, with valid measures included in a programmed software to calculate the average real variability of these measures.

Other

MeasureTime frame
Sex Differences in Ambulatory Blood Pressure Monitoring, Office Blood Pressure, Endothelial Function and Blood Pressure Variability60 minutes and 24 hours after control and power training exercise session

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026